AxoGen Announces Pricing of Public Offering of Common Stock

11/16/17

ALACHUA, Fla., Nov. 16, 2017 (GLOBE NEWSWIRE) -- AxoGen, Inc. (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions for the repair of peripheral nerve damage, announced today that it has priced an underwritten public offering of its common stock. The offering consists of 700,000 shares being sold by AxoGen and 1,000,000 shares being sold by EW Healthcare Partners L.P., formerly named Essex Woodlands Fund IX L.P., the selling shareholder, at $21.00 per share. In addition, AxoGen and the selling shareholder have granted the underwriters a 30-day option to purchase up to an aggregate of 255,000 shares of common stock at the same price. The offering is expected to close on or about November 20, 2017, subject to satisfaction of customary closing conditions.

AxoGen intends to use the net proceeds from the proposed offering for general corporate purposes. AxoGen will not receive any proceeds from the sale of shares by the selling shareholder.

Leerink Partners is acting as lead book-running manager for the offering. Cantor Fitzgerald & Co. and JMP Securities are acting as co-managers.

About AxoGen

AxoGen (AXGN) is the leading company focused specifically on the science, development and commercialization of technologies for peripheral nerve regeneration and repair. We are passionate about helping to restore nerve function and quality of life to patients with peripheral nerve injuries by providing innovative, clinically proven and economically effective repair solutions for surgeons and health care providers. Peripheral nerves provide the pathways for both motor and sensory signals throughout the body. Every day, people suffer traumatic injuries or undergo surgical procedures that impact the function of their peripheral nerves. Damage to a peripheral nerve can result in the loss of muscle or organ function, the loss of sensory feeling, or the initiation of pain.

It's on us. Share your news here.

Submit your stories and articles to citybizlist today.